Correlations between synthetic peptide-based enzyme immunoassays and immunofluorescence assay for detection of human herpesvirus 8 antibodies in different Argentine populations

Journal of Medical Virology

Volumn 78, Issue 6, 2006, Pages 806-813

  Pérez, Celeste ^a   Tous, Mónica ^a   Benetucci, Jorge ^b   Gómez, Jorge ^a  

^a INSTITUTO NACIONAL DE ENFERMEDADES INFECCIOSAS   (Argentina)

^b Laboratorio de Retrovirus   (Argentina)

Author keywords

EIA; HHV 8; HIV; IFA; Seroprevalence

Indexed keywords

CHIMERIC PROTEIN; MULTIANTIGENIC PEPTIDE PK8.1 MAP; PEPTIDE PK8.1 ORF65; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG;

ADULT; ANTIBODY DETECTION; ANTIBODY TITER; ARGENTINA; ARTICLE; BLOOD DONOR; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; ENZYME IMMUNOASSAY; FEMALE; HERPES VIRUS INFECTION; HETEROSEXUALITY; HOMOSEXUALITY; HUMAN; HUMAN HERPESVIRUS 8; IMMUNOFLUORESCENCE TEST; INTRAVENOUS DRUG ABUSE; KAPOSI SARCOMA; MAJOR CLINICAL STUDY; MALE; MALE HOMOSEXUAL; PATIENT SELECTION; SEROEPIDEMIOLOGY; SEROPREVALENCE; SYNTHETIC PEPTIDE BASED ENZYME IMMUNOASSAY; TREND STUDY;

ADULT; AGING; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; ARGENTINA; BLOOD DONORS; CHILD; CHILD, PRESCHOOL; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 8, HUMAN; HIV INFECTIONS; HOMOSEXUALITY, MALE; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; ODDS RATIO; RISK FACTORS; SENSITIVITY AND SPECIFICITY;

HERPESVIRIDAE; HUMAN HERPESVIRUS 8;

EID: 33646476162     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.20627     Document Type: Article

References (39)

1. Ablashi D, Chatlynne L, Cooper H, Thomas D, Yadav M, Norhanom AW, Chandana AK, Churdboonchart V, Kulpradist SA, Patnaik M, Liegmann K, Masood R, Reitz M, Cleghorn F, Manns A, Levine PH, Rabkin C, Biggar R, Jensen F, Gill P, Jack N, Edwards J, Whitman J, Boshoff C. 1999. Seroprevalence of human herpesvirus-8 (HHV-8) in countries of Southeast Asia compared to the USA, the Caribbean and Africa. Br J Cancer 81:893-897.
2. Ablashi DV, Chatlynne LG, Whitman JE, Jr., Cesarman E. 2002. Spectrum of Kaposi's sarcoma-associated herpesvirus, or human herpesvirus 8, diseases. Clin Microbiol Rev 15:439-464.
3. Albrecht D, Meyer T, Lorenzen T, Stoehr A, Arndt R, Plettenberg A. 2004. Epidemiology of HHV-8 infection in HIV-positive patients with and without Kaposi sarcoma: Diagnostic relevance of serology and PCR. J Clin Virol 30:145-149.
4. Andre S, Schatz O, Bogner JR, Zeichhardt H, Stoffler-Meilicke M, Jahn HU, Ullrich R, Sonntag AK, Kehm R, Haas J. 1997. Detection of antibodies against viral capsid proteins of human herpesvirus 8 in AIDS-associated Kaposi's sarcoma. J Mol Med 75:145-152.
5. Casper C, Krantz E, Taylor H, Dalessio J, Carrell D, Wald A, Corey L, Ashley R. 2002. Assessment of a combined testing strategy for detection of antibodies to human herpesvirus 8 (HHV-8) in persons with Kaposi's sarcoma, persons with asymptomatic HHV-8 infection, and persons at low risk for HHV-8 infection. J Clin Microbiol 40:3822-3825.
6. Challine D, Roudot-Thoraval F, Sarah T, Laperche L, Boisson B, Mauberquez S, Dubernet F, Rigot P, Lefrere F, Mercier B, Brossard Y, Rouet F, Girot R, Loiseau P, Girard D, Claquin J, Loty B, Lerable J, Mariotti M, Pawlotsky JM, Lefrere JJ. 2001. Seroprevalence of human herpes virus 8 antibody in populations at high or low risk of transfusion, graft, or sexual transmission of viruses. Transfusion 41:1120-1125.
7. Chandran B, Bloomer C, Chan SR, Zhu L, Goldstein E, Horvat R. 1998. Human herpesvirus-8 ORF K8.1 gene encodes immunogenic glycoproteins generated by spliced transcripts. Virology 249:140-149.
8. Chatlynne LG, Lapps W, Handy M, Huang YQ, Masood R, Hamilton AS, Said JW, Koeffler HP, Kaplan MH, Friedman-Kien A, Gill PS, Whitman JE, Ablashi DV. 1998. Detection and titration of human herpesvirus-8-specific antibodies in sera from blood donors, acquired immunodeficiency syndrome patients, and Kaposi's sarcoma patients using a whole virus enzyme-linked immunosorbent assay. Blood 92:53-58.
9. Chen N, Nelson KE, Jenkins FJ, Suriyanon V, Duerr A, Costello C, Robison V, Jacobson LP. 2004. Seroprevalence of human herpesvirus 8 infection in Northern Thailand. Clin Infect Dis 39:1052-1058.
10. Davis DA, Humphrey RW, Newcomb FM, O'Brien TR, Goedert JJ, Straus SE, Yarchoan R. 1997. Detection of serum antibodies to a Kaposi's sarcoma-associated herpesvirus-specific peptide. J Infect Dis 175:1071-1079.
11. Dollard SC, Nelson KE, Ness PM, Stambolis V, Kuehnert MJ, Pellett PE, Cannon MJ. 2005. Possible transmission of human herpesvirus-8 by blood transfusion in a historical United States cohort. Transfusion 45:500-503.
12. Dukers NH, Renwick N, Prins M, Geskus RB, Schulz TF, Weverling GJ, Coutinho RA, Goudsmit J. 2000. Risk factors for human herpesvirus 8 seropositivity and seroconversion in a cohort of homosexual men. Am J Epidemiol 151:213-224.
13. Enbom M, Sheldon J, Lennette E, Schulz T, Ablashi DV, Neipel F, Biberfeld P, Carlberg H, Ljungman P, Nilsson A, Soderstrom T, Wadstrom J, Linde A. 2000. Antibodies to human herpesvirus 8 latent and lytic antigens in blood donors and potential high-risk groups in Sweden: Variable frequencies found in a multicenter serological study. J Med Virol 62:498-504.
14. Fleiss JL. 1981. Statistical methods for rates & proportions. New York: Wiley & Sons.
15. Freitas RB, Freitas MR, Linhares AC. 2002. Prevalence of human herpesvirus 8 antibodies in the population of Belem, Para, Brazil. Rev Inst Med Trop Sao Paulo 44:309-313.
16. Gao SJ, Kingsley L, Li M, Zheng W, Parravicini C, Ziegler J, Newton R, Rinaldo CR, Saah A, Phair J, Detels R, Chang Y, Moore PS. 1996. KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma. Nat Med 2:925-928.
17. Hudnall SD, Chen T, Rady P, Tyring S, Allison P. 2003. Human herpesvirus 8 seroprevalence and viral load in healthy adult blood donors. Transfusion 43:85-90.
18. Inoue N, Mar EC, Dollard SC, Pau CP, Zheng Q, Pellett PE. 2000. New immunofluorescence assays for detection of Human herpesvirus 8-specific antibodies. Clin Diagn Lab Immunol 7:427-435.
19. Jacobson LP, Jenkins FJ, Springer G, Munoz A, Shah KV, Phair J, Zhang Z, Armenian H. 2000. Interaction of human immunodeficiency virus type 1 and human herpesvirus type 8 infections on the incidence of Kaposi's sarcoma. J Infect Dis 181:1940-1949.
20. Juhasz A, Remenyik E, Konya J, Veress G, Begany A, Andirko I, Medgyessy I, Hunyadi J, Gergely L. 2001. Prevalence and age distribution of human herpesvirus-8 specific antibodies in Hungarian blood donors. J Med Virol 64:526-530.
21. Katano H, Iwasaki T, Baba N, Terai M, Mori S, Iwamoto A, Kurata T, Sata T. 2000. Identification of antigenic proteins encoded by human herpesvirus 8 and seroprevalence in the general population and among patients with and without Kaposi's sarcoma. J Virol 74: 3478-3485.
22. Kedes DH, Operskalski E, Busch M, Kohn R, Flood J, Ganem D. 1996. The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus): Distribution of infection in KS risk groups and evidence for sexual transmission. Nat Med 2:918-924.
23. Lam LL, Pau CP, Dollard SC, Pellett PE, Spira TJ. 2002. Highly sensitive assay for human herpesvirus 8 antibodies that uses a multiple antigenic peptide derived from open reading frame K8.1. J Clin Microbiol 40:325-329.
24. Lang D, Hinderer W, Rothe M, Sonneborn HH, Neipel F, Raab M, Rabenau H, Masquelier B, Fleury H. 1999. Comparison of the immunoglobulin-G-specific seroreactivity of different recombinant antigens of the human herpesvirus 8. Virology 260:47-54.
25. Leao JC, Hinrichsen SL, de Freitas BL, Porter SR. 1999. Human herpes virus 8 and Kaposi's sarcoma. Rev Assoc Med Bras 45:55-62.
26. Lennette ET, Blackbourn DJ, Levy JA. 1996. Antibodies to human herpesvirus type 8 in the general population and in Kaposi's sarcoma patients. Lancet 348:858-861.
27. Martin JN. 2003. Diagnosis and epidemiology of human herpesvirus 8 infection. Semin Hematol 40:133-142.
28. Martin JN, Ganem DE, Osmond DH, Page-Shafer KA, Macrae D, Kedes DH. 1998. Sexual transmission and the natural history of human herpesvirus 8 infection. N Engl J Med 338:948-954.
29. Martin JN, Amad Z, Cossen C, Lam PK, Kedes DH, Page-Shafer KA, Osmond DH, Forghani B. 2000. Use of epidemiologically well-defined subjects and existing immunofluorescence assays to calibrate a new enzyme immunoassay for human herpesvirus 8 antibodies. J Clin Microbiol 38:696-701.
30. Martro E, Bulterys M, Stewart JA, Spira TJ, Cannon MJ, Thacher TD, Bruns R, Pellett PE, Dollard SC. 2004. Comparison of human herpesvirus 8 and Epstein-Barr virus seropositivity among children in areas endemic and non-endemic for Kaposi's sarcoma. J Med Virol 72:126-131.
31. Pau CP, Lam LL, Spira TJ, Black JB, Stewart JA, Pellett PE, Respess RA. 1998. Mapping and serodiagnostic application of a dominant epitope within the human herpesvirus 8 ORF 65-encoded protein. J Clin Microbiol 36:1574-1577.
32. Pellett PE, Wright DJ, Engels EA, Ablashi DV, Dollard SC, Forghani B, Glynn SA, Goedert JJ, Jenkins FJ, Lee TH, Neipel F, Todd DS, Whitby D, Nemo GJ, Busch MP. 2003. Multicenter comparison of serologic assays and estimation of human herpesvirus 8 seroprevalence among US blood donors. Transfusion 43:1260-1268.
33. Perez C, Tous M, Gallego S, Zala N, Rabinovich O, Garbiero S, Martinez MJ, Cunha AM, Camino S, Camara A, Costa SC, Larrondo M, Francalancia V, Landreau F, Bartomioli MA. 2004. Seroprevalence of human herpesvirus-8 in blood donors from different geographical regions of Argentina, Brazil, and Chile. J Med Virol 72:661-667.
34. Raab MS, Albrecht JC, Birkmann A, Yaguboglu S, Lang D, Fleckenstein B, Neipel F. 1998. The immunogenic glycoprotein gp35-37 of human herpesvirus 8 is encoded by open reading frame K8.1. J Virol 72:6725-6731.
35. Renwick N, Halaby T, Weverling GJ, Dukers NH, Simpson GR, Coutinho RA, Lange JM, Schulz TF, Goudsmit J. 1998. Seroconversion for human herpesvirus 8 during HIV infection is highly predictive of Kaposi's sarcoma. Aids 12:2481-2488.
36. Schulz TF. 2000. KSHV (HHV8) infection. J Infect 41:125-129.
37. Simpson GR, Schulz TF, Whitby D, Cook PM, Boshoff C, Rainbow L, Howard MR, Gao SJ, Bohenzky RA, Simmonds P, Lee C, de Ruiter A, Hatzakis A, Tedder RS, Weller IV, Weiss RA, Moore PS. 1996. Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen. Lancet 348:1133-1138.
38. Smith MS, Bloomer C, Horvat R, Goldstein E, Casparian JM, Chandran B. 1997. Detection of human herpesvirus 8 DNA in Kaposi's sarcoma lesions and peripheral blood of human immunodeficiency virus-positive patients and correlation with serologic measurements. J Infect Dis 176:84-93.
39. Spira TJ, Lam L, Dollard SC, Meng YX, Pau CP, Black JB, Burns D, Cooper B, Hamid M, Huong J, Kite-Powell K, Pellett PE. 2000. Comparison of serologic assays and PCR for diagnosis of human herpesvirus 8 infection. J Clin Microbiol 38:2174-2180.